<DOC>
	<DOCNO>NCT02604693</DOCNO>
	<brief_summary>This study provide important result aim , also provide integrative transcriptional epigenomic profile CBD . In Aim 1 Investigator define genome-wide epigenetic alteration CBD , determine gene DM pivotal immune cell , target organ ( CD4+ BAL cell ) CBD compare BeS healthy control . In addition , Investigator determine impact Be exposure methylation profile CBD BeS cell compare normal control . This information use define DM region , gene network . Using case control Aim 1 , evaluate gene-expression subject Aim 2 define functional epigenetic locus base DE CD4+ BAL cell without Be exposure . The Investigator also integrate ENCODE/RE methylation , histone modification , chromatin accessibility data well genome-wide association study ( GWAS ) data prioritize epigenetic mark network confirmation validation Aim 3 . In Aim 3 , Investigator test generalizability finding , explore potential methylation mark biomarkers disease PBMCs determine change methylation target AZA folic acid affect key immune regulatory pathway second set CBD BeS subject . Throughout Aims , Investigator use fresh CD4+ T cell directly assess disease relevance Be-stimulated culture CD4+ T cell ( compare unstimulated cultured T cell ) ass impact environmental exposure .</brief_summary>
	<brief_title>Exposure Epigenetic Regulation Immune Response Chronic Beryllium Disease ( CBD )</brief_title>
	<detailed_description />
	<mesh_term>Berylliosis</mesh_term>
	<criteria>Chronic Beryllium Disease ( CBD ) : 1 . History Beryllium exposure 2 . Positive blood and/or bronchoalveolar lavage ( BAL ) Beryllium Lymphocyte Proliferation Tests ( BeLPT ) 3 . Biopsyproven pathologic change consistent CBD , specifically noncaseating granuloma and/or mononuclear cell interstitial infiltrates . Beryllium Sensitization : 1 . History Beryllium exposure 2 . Two positive blood beryllium lymphocyte proliferation test ( BeLPT ) positive bronchoalveolar lavage ( BAL ) BeLPT 3 . Normal lung tissue ( histology suggestive CBD ) . Normal Controls : 1 . No history beryllium exposure 2 . Former smoker never smoker Chronic Beryllium Disease : 1 . Immunosuppressive therapy within last three month 2 . Current cigarette smoking smoking within six month prior study 3 . Positive lung wash biopsy culture fungi , mycobacteria respiratory pathogen consistent acute chronic infection 4 . Weight le 110 lb . ( venipuncture ) 5 . Pregnancy 6 . Severe room air hypoxemia hypercapnia ( preclude BAL ) , e.g. , rest PaO2 &lt; 45 , PaCO2 &gt; 45 mm Hg ; ( Denver altitude 5,280 foot ) 7 . Presence another disease may expect significantly affect patient mortality immune response ( e.g. , HIV , HCV , cancer , uncorrected bleeding diathesis , acute hypercapnia rest PaCO2 45 mm Hg ; serious cardiac arrhythmia , recent myocardial infarction within 6 week ) 8 . Patient inability participate study , inability undergo venipuncture BAL procedures form part inclusion/exclusion criterion part outcome measure Beryllium Sensitization : 1 . Known underlying systemic lung disease ; 2 . Current cigarette smoking smoking within six month prior study 3 . Positive lung pathology consistent CBD 4 . Pregnancy 5 . Weight le 110 lb . ( venipuncture ) 6 . Presence another disease may expect significantly affect patient mortality immune response ( e.g. , HIV , HCV , cancer , uncorrected bleeding diathesis , serious cardiac arrhythmia ; recent myocardial infarction within 6 week ) 7 . Patient inability participate study , inability undergo venipuncture BAL procedures form part inclusion/exclusion criterion part outcome measure Normal Controls : 1 . History beryllium exposure 2 . Known underlying systemic lung disease ; 3 . Immunosuppressive therapy medication systemic disease process last 3 month ; 4 . Current smoker smoke within 6 month study 5 . Pregnancy 6 . Weight le 110 lb . ( venipuncture ) 7 . Inability undergo BAL venipuncture procedure</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>